P7N-21702-72232
4 vaccinations
2 coded responses
12 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 020 / MA
- Registered
- 2021-04-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-20
Dose 1 — Pfizer-BioNTech
-
2021-04-10
Dose 2 — Pfizer-BioNTech
-
2021-04-20
Registered in v-safe
-
2021-04-20
Survey response — day 7, dose 2MedDRA: Heavy menstrual bleeding — Feeling: Good · HeadacheFree text: Heavy periodMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-24
- 2021-05-03
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-07-12
- 2021-10-09
-
2021-12-01
Dose 3 — Moderna
- 2022-04-12
-
2022-10-29
Dose 4 — Pfizer-BioNTech
- 2022-11-02
- 2022-11-03
-
2022-11-12
Survey response — day 14, dose 4MedDRA: Pneumonia — Feeling: Good · Be unable to work or attend schoolFree text: PneumoniaMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-20 | Pfizer-BioNTech | |
| 2 | 2021-04-10 | Pfizer-BioNTech | |
| 3 | 2021-12-01 | Moderna | No |
| 4 | 2022-10-29 | Pfizer-BioNTech | No |
Free text
Release 7 — day 7, dose 2
Systemic reaction (other): Heavy period
Release 12 — day 14, dose 4
Symptoms: Pneumonia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pneumonia | · | · | ✓ |
| SRO | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release